Klichinsky Michael

Chief Scientific OfficerCarisma Therapeutics Inc. (CARM) · full profile →Form 4 · filed Oct 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$124K
Net Open-Market Flow
-$124K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2025Sell(S)119K$0.26$31K0
Oct 2, 2025Sell(S)200K$0.25$50K119K
Oct 1, 2025Sell(S)165K$0.26$43K319K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-096740) within minutes of acceptance. Every field above traces to the original document. Verify it directly: